Volatile glycosides from the leaves of Morus alba with a potential contribution to the complex anti-diabetic activity

Natural Product Communications

Volumn 9, Issue 2, 2014, Pages 145-147

  Hunyadi, Attila ^a   Herke, Ibolya ^a   Veres, Katalin ^a   Erdei, Anna ^a   Simon, András ^b   Tóth, Gábor ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

Author keywords

Anti diabetic; GC MS; Megastigmane glycoside; Morus alba; Mulberry leaves; NIDDM; Phenyl propane; Type 2 diabetes

Indexed keywords

AGLYCONE; ANTIDIABETIC AGENT; BETA DEXTRO GLUCOSIDE; MEGASTIGMANE DERIVATIVE; MULBERRY EXTRACT; PLANT GLYCOSIDE; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ARTICLE; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; DRUG SOLUTION; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; MASS FRAGMENTOGRAPHY; MORUS ALBA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PLANT LEAF; PLANT ROOT; PROTON NUCLEAR MAGNETIC RESONANCE;

DIABETES MELLITUS, TYPE 2; GLYCOSIDES; HYPOGLYCEMIC AGENTS; MORUS; PHYTOTHERAPY; PLANT LEAVES; VOLATILIZATION;

EID: 84894495088     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1400900201     Document Type: Article

References (24)

1. WHO factsheet No. 312 (2013) Diabetes. Available at http://www.who.int/ mediacentre/factsheets/fs312/en/
2. Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P, for the Clinical Guidelines Committee of the American College of Physicians. (2012) Annals of Internal Medicine, 156, 218-231.
3. (a) Hussain Z, Waheed A, Qureshi RA, Burdi DK, Verspohl EJ, Khan N, Hasan M. (2004) The effect of medicinal plants of Islamabad and Murree region of Pakistan on insulin secretion from INS-1 cells. Phytotherapy Research, 18, 73-77;
4. (b) Singab AN, El-Beshbishy HA, Yonekawa M, Nomura T, Fukai T. (2005) Hypoglycemic effect of Egyptian Morus alba root bark extract: Effect in diabetes and lipid peroxidation of streptozocin-induced diabetic rats. Journal of Ethnopharmacology, 100, 333-338;
5. (c) Lemus I, García R, Delvillar E, Knop G. (1999) Hypoglycaemic activity of four plants used in Chilean popular medicine. Phytotherapy Research, 13, 91-94.
6. Hunyadi A, Martins A, Hsieh TJ, Seres A, Zupkó I. (2012) Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats. PLoS ONE, 7, e50619.
7. (a) Asano N, Oseki K, Tomioka E, Kizu H, Matsui K. (1994) N-containing sugars from Morus alba and their glycosidase inhibitory activities. Carbohydrate Research, 259, 243-255;
8. (b) Taniguchi S, Asano N, Tomino F, Miwa I. (1998) Potentiation of glucose induced insulin secretion by fagomine, a pseudo-sugar isolated from mulberry leaves. Hormone and Metabolic Research, 30, 679-683.
9. (a) Hikino H, Mizuno T, Oshima Y, Konno C (1985) Isolation and hypoglycemic activity of Moran A, a glycoprotein of Morus alba root barks. Planta Medica, 2, 159-160;
10. (b) Kim ES, Park SJ, Lee EJ, Kim BK, Huh H, Lee BJ. (1999) Purification and characterization of Moran 20K from Morus alba. Archives of Pharmacal Research, 22, 9-12.
11. Ma QY, Shi GQ, Chen CT, Sun J, Chen XY. (2006) Studies on inhibitor effects and activator of α-glucosidase in mulberry leaves. Food Science, 27, 108-111.
12. (a) Takemoto T, Ogawa S, Nishimoto N, Hirayama H, Taniguchi S. (1967) Isolation of the insect-molting hormones from mulberry leaves. Yakugaku Zasshi, 87, 748
13. (b) Lafont R, Dinan L. (2003) Practical uses for ecdysteroids in mammals including humans: an update. Journal of Insect Science, 3:7, 1-30.
14. Hunyadi A, Veres K, Danko B, Kele Z, Weber E, Hetenyi A, Zupko I, Hsieh TJ. (2013) In vitro antidiabetic activity and chemical composition of an apolar fraction of Morus alba leaf water extract. Phytotherapy Research, 27, 847-851.
15. Kim MR, Lee SK, Kim CS, Kim KS, Moon DC. (2004) Phytochemical constituents of Carpesium macrocephalum F(R). et S(AV). Archives of Pharmacal Research, 27, 1029-1033.
16. Park JH, Lee DG, Yeon SW, Kwon HS, Ko JH, Shin DJ, Park HS, Kim YS, Bang MH, Baek NI. (2011) Isolation of megastigmane sesquiterpenes from the silkworm (Bombyx mori L.) droppings and their promotion activity on HO-1 and SIRT1. Archives of Pharmacal Research, 34, 533-542.
17. (a) Lee EH, Kim HJ, Song YS, Jin C, Lee KT, Cho J, Lee YS. (2003) Constituents of the stems and fruits of Opuntia ficus-indica var. saboten. Archives of Pharmacal Research, 26, 1018-1023;
18. (b) Matsunami K, Otsuka H, Takeda Y. (2010) Structural revisions of blumenol C glucoside and byzantionoside B. Chemical & Pharmaceutical Bulletin, 58, 438-441.
19. Khan SH, Mosihuzzaman M, Nahar N, Rashid MA, Rokeya B, Ali L, Azad Khan AK. (2003) Three megastigmane glycosides from the leaves of Pterospermum semisagittatum. Pharmaceutical Biology, 41, 512-515.
20. (a) Wiley Subscription Services, Inc. (USA) CAS2009-1-079186;
21. (b) Wiley Subscription Services, Inc. (USA) CAS2009-1-081982.
22. (a) Duddeck H, Dietrich W, Tóth G. (1998) Structure elucidation by modern NMR. Springer-Steinkopff, Darmstadt;
23. (b) Pretsch E, Tóth G, Munk ME, Badertscher M. (2002) Computer-aided Structures Elucidation. Spectra Interpretation and Structure Generation. Wiley-VCH, Weinheim.
24. Csupor D, Boros K, Hunyadi A, Veres K, Hohmann J. (2012) Validation of a densitometric method for the determination of theanine in tea extracts using CP atlas software. Journal of Planar Chromatography, 25, 571-574.